This newslink doesn't exist or it was removed.
Go to Homempage.
ABC News USA Business September 05, 2023
A company that sold triggers that make semi-automatic, AR-15-style rifles fire like automatic weapons likely misled consumers that the devices were legal, and it continued selling them even after being warned by the U.S. government, a federal judge in New York ruled Tuesday.The... + más
Yes, Your Job Is Important. But It’s Not All-Important. | The New York Times
6 warning signs someone may be a sociopath, according to a psychotherapist who's trained the FBI and CIA | Business Insider
CNBC USA Health December 06, 2022
Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.Dado Ruvic Reuters has rejected allegations made by rival that its Covid-19 vaccine is a copy, accusing the Boston biotech company of... + más
Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate
Moderna is suing Pfizer over its coronavirus vaccine | The Verge
CNBC USA Health November 02, 2022
Pfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021.John Thys AFP Getty Images... + más
Pfizer raises 2022 earnings guidance, beats third-quarter expectations | CNBC
Pfizer climbs on strong Q3 results, raised outlook | MarketWatch
Business Insider USA Business November 09, 2022
Goldman Sachs promoted 80 people to partner status on Wednesday, marking the largest class since David Solomon took over as CEO in 2018.Twenty-three of the new members are women and seven identify as black — the highest ever figures in both cases, the company said. Nineteen... + más
Goldman Sachs insiders say they are concerned about CEO David Solomon's push to build his personal brand, pointing to staff help for his DJing and use of the firm's planes | Business Insider
Who's up and who's down in the latest Goldman Sachs restructuring under CEO David Solomon | Business Insider
ABC News USA Business May 02, 2023
Pfizer beat first-quarter forecasts as revenue took an expected dip, but the drugmaker predicted a sales rally later this year. The pharmaceutical giant said Tuesday that total revenue dropped 29% in quarter, as sales tumbled for its market-leading COVID-19 vaccine, Comirnaty.... + más
FDA Authorizes Bivalent Pfizer Covid Vaccine As Booster Dose For Select Children Under 5 | RTTNews
About iurex | Privacy Policy | Disclaimer |